Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 7

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 7
---
 |
| Equity Compensation Plans                                                                                |     |                                                                                 |     |  98 |
| Pay Versus Performance                                                                                   |     |                                                                                 |     |  99 |
|                                                                                                          |     | Proposal 2                                                                      
 Advisory Vote to Approve theCompensation of our Named Executive Officers        |     | 105 |
| Audit Committee Report                                                                                   |     |                                                                                 |     | 107 |
|                                                                                                          |     | Proposal3                                                                       
 Ratification of Appointment ofour Independent Registered Public Accounting Firm |     | 108 |
|                                                                                                          |     | Proposal4                                                                       
 StockholderProposalTitled“SupportSimpleMajorityVote”                            |     | 110 |
| Other Information                                                                                        |     |                                                                                 |     | 113 |
| Annex A-Reconciliations of Non-GAAP Financial Measures Used in Incentive Compensation Plans and Programs |     |                                                                                 |     | A-1 |

#### vi2025 Proxy Statement

#### Information About the Annual Meeting and Voting

#### The Annual Meeting
The 2025 Annual Meeting of Stockholders (Annual Meeting) of Boston Scientific Corporation (the Company) will be held on Thursday, May 1, 2025, at 8:00 a.m. Eastern Time. To maximize stockholder participation and provide a consistent experience regardless of location, our Annual Meeting will be held in a virtual format via live webcast over the internet. You will be able to join the Annual Meeting and vote and submit your questions online during the Annual Meeting by visiting www.virtualshareholdermeeting.com/BSX2025 . We have designed the virtual Annual Meeting to ensure stockholders are afforded the same opportunity to participate as they would have at an in-person meeting, including the right to vote and ask questions through the virtual meeting platform.

At this meeting, stockholders will be asked to elect ten nominees for director; approve, on a non-binding, advisory basis, the compensation of our named executive officers; ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2025 fiscal year; and consider and vote on a stockholder proposal titled “Support Simple Majority Vote,” if properly presented. Management will also respond to questions from stockholders.

Our principal executive offices are located at 300 Boston Scientific Way, Marlborough, Massachusetts 01752, and our telephone number is (508) 683-4000. When used in this Proxy Statement, the terms “we,” “us,” “our,” “Boston Scientific” and “the Company” mean Boston